semaglutide and hair Loss: What the Science Shows Study Offers More Evidence That

This has led to many cash-based businesses selling semaglutide to individuals who do not meet the FDA criteria of having a BMI over 30 or over 27 with additional weight-related comorbid conditions

Dosing schedule and titration protocol Semaglutide titration follows a stepped approach designed to minimize gastrointestinal side effects

One less common but disturbing potential side effect of the drug, which is sold under the brand names Ozempic and Wegovy: Hair loss

Both medications belong to the class of glucagon-like peptide 1 (GLP-1) agonists, which are approved for the treatment of type 2 diabetes

Its essential to discuss any dietary changes with your healthcare provider to ensure they are suitable for your specific needs and health condition